Buyers Drug Mart Inc. is shifting away from its medical hashish distribution enterprise and making ready to switch sufferers to a platform run by biopharmaceutical firm Avicanna Inc.
The pharmacy chain owned by Loblaw Corporations Ltd. introduced the shift Tuesday, however didn’t say what prompted the change or how a lot cash Toronto-based Avicanna is paying for Buyers to refer sufferers to its MyMedi.ca platform.
Learn extra:
Buyers Drug Mart launches platform to promote medical marijuana on-line
“We’re grateful for the belief positioned in us by our medical hashish sufferers over the previous few years, and are assured we’ve discovered the best accomplice in Avicanna to proceed to assist them,” mentioned Jeff Leger, Buyers’ president, in an announcement.
His firm will begin to ship prospects to Avicanna’s platform in early Might, with all the sufferers set to be off-loaded from Buyers’ medical pot service by the top of July. Clients will have the ability to place orders on Buyers’ web site by way of the transition interval.
Avicanna mentioned it is going to provide an analogous vary of merchandise together with varied codecs, manufacturers and “aggressive pricing.” Like Buyers, its on-line medical portal will try to coach prospects round hurt discount and supply speciality companies for distinct affected person teams like veterans.
Buyers first launched its medical hashish enterprise in Ontario in January 2019, months after leisure pot was legalized in Canada (medical pot was legalized in Canada in 2001) at a time when many predicted the weed sector can be booming within the coming years.
The sector has as a substitute struggled with profitability and as excessive numbers of leisure hashish retailers cluster in a number of cities, many retailers and licensed producers have needed to drop their costs to remain aggressive.
Nonetheless, Buyers mentioned it racked up tens of hundreds of sufferers in its 4 years of existence, offering them with entry to hashish from greater than 30 manufacturers together with Aphria Inc., Hexo Corp.’s Redecan and the Inexperienced Natural Dutchman.
Buyers’ medical hashish sufferers had been required to acquire a prescription from a licensed health-care supplier similar to a physician to start ordering pot from the corporate, which shipped orders to their properties.
However the firm was sad with how medical pot rules restricted its mannequin. Buyers claimed Tuesday that medical hashish stays the one remedy that’s not distributed in pharmacies.
Learn extra:
Buyers Drug Mart to make use of blockchain expertise to trace medical hashish high quality
“As we transfer away from medical hashish distribution, we stay agency in our perception that this remedy needs to be distributed in pharmacies like all others and can proceed our advocacy to that finish,” mentioned Leger.
Avicanna’s assertion didn’t define its emotions on the issues, however its chief government mentioned it was “motivated” to “put our full efforts towards advancing medical hashish and its incorporation into the usual of care.”
“We’re grateful to be chosen because the accomplice for this transition and stay up for introducing MyMedi.ca, supporting sufferers and offering them with continuity of care,” mentioned Avicanna chief government Aras Azadian in an announcement.
© 2023 The Canadian Press